[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Enfermedades Infecciosas y Microbiologia Clinica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19572429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis: Results from Population-Based Surveillance of Candidemia in Spain

  2008cited by this paper
• Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole

  2008cited by this paper
• EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.

  2008cited by this paper
• In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans

  2008cited by this paper
• Combination Echinocandin-Polyene Treatment of Murine Mucormycosis

  2008cited by this paper
• Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin

  2007cited by this paper
• Acquired resistance to echinocandins in Candida albicans: case report and review.

  2007cited by this paper
• A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatus

  2007cited by this paper
• Resistance to echinocandin-class antifungal drugs.

  2007cited by this paper
• Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase

  2007cited by this paper
• Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia

  2007cited by this paper
• In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

  2007cited by this paper
• Anidulafungin: a new echinocandin for candidal infections

  2007cited by this paper
• Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

  2007cited by this paper
• Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds

  2007cited by this paper
• Emergence of Candida tropicalis resistant to caspofungin.

  2007cited by this paper
• Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.

  2006cited by this paper
• Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility

  2006cited by this paper
• Escape of Candida from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by Caspofungin

  2006cited by this paper
• Anidulafungin: a novel echinocandin.

  2006cited by this paper
• Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

  2006cited by this paper
• Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species

  2006cited by this paper
• Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.

  2006cited by this paper
• Efficacy of Caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans

  2006cited by this paper
• Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways

  2005cited by this paper
• In Vitro Synergy Testing of Anidulafungin with Itraconazole, Voriconazole, and Amphotericin B against Aspergillus spp. and Fusarium spp

  2005cited by this paper
• Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

  2005cited by this paper
• Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

  2005cited by this paper
• Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

  2005cited by this paper
• Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

  2004cited by this paper
• Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

  2004cited by this paper
• Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations

  2004cited by this paper
• In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates

  2004cited by this paper
• Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)

  2003cited by this paper
• In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.

  2003cited by this paper
• Comparison of Two Methods and Three End Points in Determination of In Vitro Activity of Micafungin against Aspergillus spp

  2003cited by this paper
• Anidulafungin Vicuron.

  2003cited by this paper
• Comparative Evaluation of Disk Diffusion with Microdilution Assay in Susceptibility Testing of Caspofungin against Aspergillus and Fusarium Isolates

  2002cited by this paper
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

  2001cited by this paper
• Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.

  2000cited by this paper
• In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

  1998cited by this paper
• In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

  1997cited by this paper

• Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review

  2021cites this paper
• Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis

  2021cites this paper
• A review on antifungal agents against Candida albicans and Aspergillus niger

  2021cites this paper